The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-GFPSpark tag||CG90084-ACG|
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||CG90084-ACR|
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-Flag tag||CG90084-CF|
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-His tag||CG90084-CH|
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-Myc tag||CG90084-CM|
|Rhesus IGFBP3 ORF mammalian expression plasmid, C-HA tag||CG90084-CY|
|Rhesus IGFBP3 ORF mammalian expression plasmid, N-Flag tag||CG90084-NF|
|Rhesus IGFBP3 ORF mammalian expression plasmid, N-His tag||CG90084-NH|
|Rhesus IGFBP3 ORF mammalian expression plasmid, N-Myc tag||CG90084-NM|
|Rhesus IGFBP3 ORF mammalian expression plasmid, N-HA tag||CG90084-NY|
|Rhesus IGFBP3 natural ORF mammalian expression plasmid||CG90084-UT|
|Learn more about expression Vectors|
The Insulin-like Growth Factor (IGF) signaling system plays a central role in cellular growth, differentiation and proliferation. IGFBP3 is the most abundant IGF binding protein in human serum and has been shown to be a growth inhibitory, apoptosis-inducing molecule, capable of acting via IGF-dependent and IGF-independent mechanisms. It appears to function both by cell cycle blockade and the induction of apoptosis. IGFBP3 can be transported to the nucleus by an importin beta mediated mechanism, where it has been shown to interact with the retinoid X receptor alpha and possibly other nuclear elements. IGFBP3 antiproliferative signalling appears to require an active transforming growth factor beta (TGF-beta) signalling pathway, and IGFBP3 stimulates phosphorylation of the TGF-beta signalling intermediates Smad2 and Smad3. IGFBP3 has IGF-independent roles in inhibiting cell proliferation in cancer cell lines. Nuclear transcription factor, retinoid X receptor (RXR)-alpha, and IGFBP3 functionally interact to reduce prostate tumor growth and prostate-specific antigen in vivo. Several clinical studies have proposed that individuals with IGFBP3 levels in the upper range of normal may have a decreased risk for certain common cancers. This includes evidence of a protective effect against breast cancer, prostate cancer, colorectal cancer, and lung cancer. Moreover, IGFBP3 inhibits insulin-stimulated glucose uptake into adipocytes independent of IGF.